CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-04 | Lane Michael Executive Vice President | Sale | −242.94 | $687.85 | $167K | 7,812 |
| 2026-11-04 | Lane Michael Executive Vice President | Sale | −2,059 | $689.70 | $1.4M | 5,753 |
| 2026-11-04 | Lane Michael Executive Vice President | Sale | −1,677 | $687.46 | $1.2M | 4,076 |
| 2026-02-14 | Lane Michael Executive Vice President | Exercise or conversion | +204 | 7,356.94 | ||
| 2026-02-14 | Lane Michael Executive Vice President | Exercise or conversion | +220 | 7,576.94 | ||
| 2026-02-14 | Lane Michael Executive Vice President | Exercise or conversion | +301 | 7,877.94 | ||
| 2026-02-14 | Lane Michael Executive Vice President | Exercise or conversion | +367 | 8,244.94 | ||
| 2026-02-14 | Lane Michael Executive Vice President | Shares withheld for taxes | −221 | $629.35 | $139K | 8,023.94 |
| 2026-02-14 | Lane Michael Executive Vice President | Exercise or conversion · Restricted Stock Unit | −367 | 1,101 | ||
| 2026-02-14 | Lane Michael Executive Vice President | Exercise or conversion · Restricted Stock Unit | −204 | 0 | ||
| 2026-02-14 | Lane Michael Executive Vice President | Exercise or conversion · Restricted Stock Unit | −220 | 220 | ||
| 2026-02-14 | Lane Michael Executive Vice President | Exercise or conversion · Restricted Stock Unit | −301 | 602 | ||
| 2026-02-12 | Lane Michael Executive Vice President | Grant or award · Non-Qualified Stock Option (right-to-buy) | +5,361 | 5,361 | ||
| 2026-02-12 | Lane Michael Executive Vice President | Grant or award · Incentive Stock Option (right-to-buy) | +162 | 162 | ||
| 2026-02-12 | Lane Michael Executive Vice President | Grant or award · Restricted Stock Unit | +1,262 | 1,262 | ||
| 2026-02-12 | Lane Michael Executive Vice President | Grant or award · Restricted Stock Unit | +1,620 | 1,620 | ||
| 2025-08-06 | Lane Michael Executive Vice President | Exercise or conversion | +1,286 | $206.94 | $266K | 8,417.94 |
| 2025-08-06 | Lane Michael Executive Vice President | Exercise or conversion | +7,125 | $288.78 | $2.1M | 15,542.94 |
| 2025-08-06 | Lane Michael Executive Vice President | Sale | −5,631 | $627.56 | $3.5M | 9,911.94 |
| 2025-08-06 | Lane Michael Executive Vice President | Sale | −2,480 | $627.99 | $1.6M | 7,431.94 |
Page 1 of 4 · 77 trades